CYP cynata therapeutics limited
Add to My Watchlist 7.69% ! 1.2¢

Ann: CYP Completes Patent Application related to CAR-T Therapy, page-2

  1. possman
    3 Posts.
    lightbulb Created with Sketch.  1
    clock Created with Sketch.
    20/04/18
    09:46
    Post #: 32577757
    Separately, Cynata today announced that its license option agreement with apceth GmbH & Co. KG has been discontinued. Cynata continues to work with its development, commercialisation and research partners to advance Cymerus to patients in areas of unmet need, as well as to seek opportunities to expand its pipeline in cancer and other therapeutic areas that may benefit from stem cell therapy.
    CYP Price at posting: $1.39 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Nowhere left to hide: cash strapped AI stocks' week of truth
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
1.2¢ 		Change
-0.001(7.69%) 		Mkt cap ! $3.164M
Open High Low Volume
1.2¢ 1.2¢ 1.2¢ 862.7K

Buyers (Bids)

Vol. Price($)
3400817 1.1¢
 

Sellers (Offers)

Price($) Vol.
1.2¢ 1202817
Last trade - 16.10pm 24/07/2026 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.